Xeroderma Pigmentosum
What's New
Last Posted: Jun 22, 2023
- Squamous-Cell Carcinoma of the Skin
A Wysong, NEJM, June 21, 2023 - Xeroderma pigmentosum: an updated review.
Leung Alexander Kc et al. Drugs in context 2022 11 - Xeroderma Pigmentosum: Gene Variants and Splice Variants.
Martens Marie Christine et al. Genes 2021 12(8) - DNA Damage-Induced Neurodegeneration in Accelerated Ageing and Alzheimer's Disease.
Wang Heling et al. International journal of molecular sciences 2021 22(13) - Genetic Counseling Clinic at AIIMS (New Delhi).
Maitra Dhritiman et al. Indian journal of surgical oncology 2021 12(Suppl 1) 30-33 - Hereditary Tumor Syndromes with Skin Involvement.
Hamid Ramiz N et al. Dermatologic clinics 2019 Oct 37(4) 607-613 - Xeroderma pigmentosum.
Zghal M et al. Annales de dermatologie et de venereologie 2018 Nov 145(11) 706-722 - Use of Big Data to Estimate Prevalence of Defective DNA Repair Variants in the US Population.
Pugh Jennifer et al. JAMA dermatology 2018 Dec - Xeroderma pigmentosum clinical practice guidelines.
Moriwaki Shinichi et al. The Journal of dermatology 2017 Oct 44(10) 1087-1096 - Xeroderma pigmentosum at a tertiary care center in Saudi Arabia.
Alwatban Lenah et al. Annals of Saudi medicine 37(3) 240-244
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 03, 2024
- Content source: